FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Buprenorphine Hydrochloride Injection Recall

Buprenorphine Hydrochloride Injection, CIII, 0

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Oct 1, 2014
Recall ID
D-1604-2014
Check your lot numberHow we source this data

Summary

Hospira recalled Buprenorphine Hydrochloride Injection starting Sep 9, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1604-2014 on Oct 1, 2014. Reason: Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.

Product description

Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10 Carpuject Sterile Cartridge Units with Luer Lock, Slim-Paks, F Intramuscular or Intravenous Use, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2012-32

Lot numbers, UPCs & expiration codes

Lot Number: 35-730-LL, 35-745-LL, Exp: 1 FEB 2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1604-2014
Classification
Class II
Status
Terminated
Recall initiated
Sep 9, 2014
FDA report date
Oct 1, 2014
Quantity
373,180 Carpuject units
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1604-2014, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
69163
Address
275 N Field Dr
Code information
Lot Number: 35-730-LL, 35-745-LL, Exp: 1 FEB 2015
Postal code
60045-2579
Report date
Oct 1, 2014
Product type
Drugs
Recall number
D-1604-2014
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
373,180 Carpuject units
Termination date
Mar 17, 2017
Reason for recall
Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10 Carpuject Sterile Cartridge Units with Luer Lock, Slim-Paks, F Intramuscular or Intravenous Use, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2012-32
Distribution pattern
Nationwide
Recall initiation date
Sep 9, 2014
Center classification date
Sep 19, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1604-2014, published Oct 1, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls